Home > Insider Trading > Filing (0001179110-13-014146)

Filing Details

Accession Number:: 0001179110-13-014146
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-09-12 21:41:45
Reporting Period:: 2013-09-11

Filing Date:: 2013-09-12
Accepted Time:: 2013-09-12 21:41:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1396814	Pacira Pharmaceuticals Inc.	PCRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1511472	Andreas Wicki	Governors Square, Suite 4-212-2, 23 Lime Tree Bay Ave. West Bay Grand Cayman E9 00000		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-09-11	37,192	$2.69	1,668,136	No	4	X	Indirect	See footnote.
Common Stock	Disposition	2013-09-11	2,686	$37.25	1,665,450	No	4	S	Indirect	See footnote.
Common Stock	Acquisiton	2013-09-11	41,841	$13.44	1,707,291	No	4	X	Indirect	See footnote.
Common Stock	Disposition	2013-09-11	15,097	$37.25	1,692,194	No	4	S	Indirect	See foootnote.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	X	Indirect	See footnote.
No	4	S	Indirect	See footnote.
No	4	X	Indirect	See footnote.
No	4	S	Indirect	See foootnote.

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant (right to buy)	Disposition	2013-09-11	37,192	$0.00	37,192	$2.69
Common Stock	Warrant (right to buy)	Disposition	2013-09-11	41,841	$0.00	41,841	$13.44

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2009-01-22	2014-01-21	No	4	X	Indirect
0	2010-12-29	2017-12-29	No	4	X	Indirect

Footnotes

The board of directors of HBM Healthcare Investments (Cayman) Ltd. ("HBM") has sole voting and investment power with respect to the securities held by such entity and acts by majority vote. The reporting person does not have sole voting or investment power over the securities held by HBM. However, the reporting person may be deemed to have beneficial ownership of these securities by virtue of his membership on the board of directors of HBM. The reporting person disclaims beneficial ownership of the securities reported herein for the purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest herein, if any. This report on Form 4 shall not be deemed an admission that the reporting person is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose of Section 16 of the Exchange Act, or for any other purpose.
On September 11, 2013, HBM exercised a warrant to purchase 37,192 shares of the Issuer's common stock for $2.69 a share. HBM paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 2,686 of the warrant shares to pay the exercise price and issuing to HBM the remaining 34,506 shares. The Issuer also paid $7.02 to HBM in lieu of a fractional share.
On September 11, 2013, HBM exercised a warrant to purchase 41,841 shares of the Issuer's common stock for $13.44 a share. HBM paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 15,097 of the warrant shares to pay the exercise price and issuing to HBM the remaining 26,744 shares. The Issuer also paid $20.21 to HBM in lieu of a fractional share.